Professional Documents
Culture Documents
www. AJOG.org
ated with increased maternal hypotension or fetal heart rate (FHR) abnormalities after epidural anesthesia placement during labor.
STUDY DESIGN: This was a retrospective cohort study of women undergoing epidural anesthesia during labor at term from April 2008
through July 2010.
RESULTS: A total of 125 morbidly obese patients were matched for age
and race with 125 normal-weight patients. Morbidly obese patients had
more frequent persistent systolic (16% vs 4%, P .003) and diastolic
(49% vs 29%, P .002) hypotension and more prolonged (16% vs 5%,
P .006) and late (26% vs 14%, P .03) FHR decelerations. Increasing body mass index was associated with persistent systolic (odds ratio,
1.06; 95% confidence interval, 1.021.10) and diastolic (odds ratio,
1.04; 95% confidence interval, 1.011.06) hypotension after controlling for epidural bolus dose and hypertensive disorders.
CONCLUSION: Morbidly obese women have more hypotension and pro-
Cite this article as: Vricella LK, Louis JM, Mercer BM, et al. Impact of morbid obesity on epidural anesthesia complications in labor. Am J Obstet Gynecol
2011;205:370.e1-6.
aternal hypotension is not uncommon with labor epidural anesthesia placement, complicating 5-17%
of cases.1,2 Pregnancy increases maternal
dependence on sympathetic vascular
tone to maintain venous return and
uteroplacental perfusion.3,4 Regional
anesthesia-associated sympathectomy
with resultant maternal hypotension decreases uteroplacental perfusion and is
an important potential cause of intrapartum fetal heart rate (FHR) abnormalities
and emergent cesarean delivery. UncorFrom the Division of Maternal-Fetal
Medicine, Department of Obstetrics and
Gynecology (Drs Vricella, Louis, and Mercer),
and the Department of Anesthesiology (Dr
Bolden), MetroHealth Medical Center, Case
Western Reserve University School of
Medicine, Cleveland, OH.
Received March 9, 2011; revised May 2, 2011;
accepted June 22, 2011.
The authors report no conflict of interest.
Presented as a poster at the 31st Annual
Meeting of the Society for Maternal-Fetal
Medicine, San Francisco, CA, Feb. 7-12, 2011.
Reprints not available from the authors.
0002-9378/free
2011 Mosby, Inc. All rights reserved.
doi: 10.1016/j.ajog.2011.06.085
370.e1
SMFM Papers
www.AJOG.org
TABLE 1
Normal weight
n 125
Morbidly obese
n 125
Age, y
24 [2131]
25 [2132]
.6
Gestational age, wk
39 [3840]
39 [3840]
.6
Nulliparity, %
35
44
.2
P value
..............................................................................................................................................................................................................................................
..............................................................................................................................................................................................................................................
..............................................................................................................................................................................................................................................
1 [02]
1 [02]
.4
..............................................................................................................................................................................................................................................
Race, %
.....................................................................................................................................................................................................................................
Black
50
58
Hispanic
10
10
White
40
32
.3
.....................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................
..............................................................................................................................................................................................................................................
Insurance, %
.....................................................................................................................................................................................................................................
Public
84
84
.1
Private
16
16
.1
.....................................................................................................................................................................................................................................
..............................................................................................................................................................................................................................................
2
BMI, kg/m
.....................................................................................................................................................................................................................................
Pregravid
20 [1821]
41 [3946]
.0001
Delivery
24 [2325]
45 [4249]
.0001
2 [22]
2 [22]
.4
.....................................................................................................................................................................................................................................
..............................................................................................................................................................................................................................................
ASA score, U
..............................................................................................................................................................................................................................................
Medical comorbidities, %
.....................................................................................................................................................................................................................................
18
.0001
Preeclampsia spectrum
10
20
.05
Diabetes, pregestational
.03
10
.006
10
15
.3
Chronic hypertension
.....................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................
Diabetes, gestational
.....................................................................................................................................................................................................................................
Asthma
..............................................................................................................................................................................................................................................
Statistical analysis
We note that a 5% incidence of hypotension has been found in the general
population during epidural catheter
placement for labor when intravenous
preloading is performed.1,14 A priori
analysis demonstrated that to detect a 15%
incidence of hypotension in morbidly
obese women, at an alpha of 0.05 and a
beta of 0.2, 100 women would be needed
in each group. Statistical analyses were
performed using commercially available
software (SPSS, version 18.0; SPSS Inc,
Chicago, IL). We evaluated differences
between the groups using the Student t
test for continuous variables, and the
Mann-Whitney U test and Fishers exact
tests for categorical variables. We then
370.e2
SMFM Papers
performed multinomial logistic regressions for factors predictive of persistent
systolic hypotension, persistent diastolic
hypotension, and FHR abnormalities.
Factors included in the models for persistent systolic and persistent diastolic
hypotension were BMI, preeclampsia
spectrum conditions, chronic hypertension, and epidural anesthetic bolus.
Factors included in the model for FHR
abnormalities were BMI, preeclampsia
spectrum conditions, chronic hypertension, epidural anesthetic bolus, persistent systolic hypotension, and persistent
diastolic hypotension. P .05 was significant. This retrospective chart review
was approved by the institutional review
board at MetroHealth Medical Center,
Cleveland, OH.
www.AJOG.org
TABLE 2
Normal weight
n 125
Morbidly obese
n 125
P value
21
47
.0001
10
.3
.1
.....................................................................................................................................................................................................................................
Oligohydramnios
.....................................................................................................................................................................................................................................
..............................................................................................................................................................................................................................................
Delivery, %
.....................................................................................................................................................................................................................................
Spontaneous vaginal
93
72
.0001
Operative vaginal
.03
Cesarean
20
.001
10
.01
.....................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................
..............................................................................................................................................................................................................................................
Apgar score
.....................................................................................................................................................................................................................................
1 min
9 [99]
9 [99]
.9
5 min
9 [99]
9 [99]
.9
.....................................................................................................................................................................................................................................
..............................................................................................................................................................................................................................................
Infant weight, g
3132 417
3380 465
.0001
..............................................................................................................................................................................................................................................
R ESULTS
A total of 125 morbidly obese women
met inclusion criteria and were matched
by age and race with 125 normal-weight
women. Both groups were similar in age,
gestational age at delivery, race, insurance
status, parity, and frequency of asthma
(Table 1). Morbidly obese women had
more frequent chronic hypertension, preeclampsia spectrum disorders (gestational
hypertension, mild and severe preeclampsia, eclampsia), and diabetes (gestational
and pregestational).
Regarding delivery and anesthesia
outcomes, morbidly obese women had
more frequent labor induction, cesarean
delivery, operative vaginal delivery, and
emergent delivery for FHR abnormalities (Table 2). Rates of antepartum diagnosis of oligohydramnios and intrauterine growth restriction were similar in
both groups. Apgar scores at 1 and 5
minutes were similar between groups.
Infants born to morbidly obese women
were heavier than those of normalweight women (3380 465 g vs 3132
417 g, P .0001).
Morbidly obese women had similar
rates of initial successful epidural catheter placement and the groups were similar in initial and total epidural anesthetic
bolus dose administered over the first
hour. Morbidly obese women received
more frequent and higher doses of intra370.e3
.....................................................................................................................................................................................................................................
No. of attempts
1 [11]
1 [11]
.1
4.7 0.9
4.8 1.0
.5
.....................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................
5.5 1.9
5.3 1.6
.3
.....................................................................................................................................................................................................................................
Anesthesia level
T9 [T7T10]
T8 [T6T9]
.1
..............................................................................................................................................................................................................................................
Phenylephrine
.....................................................................................................................................................................................................................................
Any dose, %
14
.3
.....................................................................................................................................................................................................................................
Total dose, g
345 280
702 1058
.2
..............................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................
Systolic
125 14
130 16
Diastolic
76 12
76 12
.1
.....................................................................................................................................................................................................................................
..............................................................................................................................................................................................................................................
venous pressor support with phenylephrine than normal-weight women; however the differences were not significant.
Although morbidly obese women had
more frequent chronic hypertension and
preeclampsia spectrum disorders, baseline blood pressures taken immediately
before epidural dosing were similar between groups.
A single episode of postepidural hypotension occurred frequently in both
morbidly obese and normal-weight
groups (systolic hypotension: 44% vs
30%, P .04; diastolic hypotension:
75% vs 66%, P .2) (Figure). Persistent
diastolic hypotension was more common than persistent systolic hypotension across both groups and persistent
SMFM Papers
www.AJOG.org
FIGURE
tions were more common among morbidly obese women (6% vs 1%, P .04).
Morbidly obese women were twice as
likely to have a change from a category I
tracing preepidural dosing to a category
II tracing after epidural dosing (P .02)
and also more frequently developed a
nonreassuring tracing than normalweight women (36% vs 20%, P .007).
Logistic regression analysis was performed to determine factors predictive
of maternal hypotension and FHR abnormalities (Table 4). Each unit increase
in BMI was associated with an increased
risk of both persistent systolic and persistent diastolic hypotension after controlling for epidural bolus dose and
hypertensive disorders. Epidural bolus
dose was associated with persistent diastolic hypotension, but not persistent
systolic hypotension. Increasing BMI,
persistent systolic hypotension, and persistent diastolic hypotension were each
associated with new onset of late or prolonged variable decelerations after controlling for hypertensive disorders and
epidural anesthetic bolus dose.
C OMMENT
We found that morbidly obese women
given similar bolus doses of epidural anesthetic had more frequent postepidural
TABLE 3
Normal weight
n 125
Morbidly obese
n 125
P value
Prolonged decelerations
16
Decreased variability
.006
Late decelerations
14
26
.03
Nonreassuring tracing
20
36
.007
..............................................................................................................................................................................................................................................
1.0
..............................................................................................................................................................................................................................................
..............................................................................................................................................................................................................................................
..............................................................................................................................................................................................................................................
Variable decelerations
.....................................................................................................................................................................................................................................
Mild
1.0
Moderate
11
.1
Severe
1.0
14
35
.0001
Tachysystole-associated
.04
16
30
.02
.....................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................
..............................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................
..............................................................................................................................................................................................................................................
Category I-II
..............................................................................................................................................................................................................................................
hypotension and related late or prolonged FHR decelerations than normalweight controls. We also found that
diastolic hypotension occurred more
frequently among both BMI groups than
systolic hypotension. Increasing BMI is
associated with increased risk of persistent postepidural hypotension and subsequent late or prolonged variable decelerations. The incidence of persistent
diastolic hypotension was positively related to the increasing epidural anesthetic dose.
Our finding of a high overall incidence
of epidural-related hypotension is not
surprising as it is a well-documented
consequence of regional anesthesia in
pregnancy.3,4 In a term patient progressively dependent on the sympathetic
nervous system for hemodynamic stability, pharmacologic sympathectomy can
compromise venous return and uteroplacental perfusion.3,4 Our findings that
diastolic blood pressures decreased more
than systolic blood pressures is in keeping with prior studies documenting decreasing systemic vascular resistance
during pregnancy that affects diastolic
blood pressures to a greater extent.15
However, we found that both persistent
systolic and diastolic hypotension were
associated with the occurrence of late or
prolonged variable decelerations. This
finding suggests that although diastolic
hypotension occurred more frequently
than systolic, both contribute to maintaining uteroplacental perfusion to some
extent.
The cause of increased hypotension in
morbidly obese women compared to
normal-weight women is likely multifactorial; however we propose 2 possible
mechanisms: anatomic distortion of the
epidural space and inadequate volume
preloading. The epidural space is smaller
and epidural space pressures are higher
in obese women at term due to increased
density and engorgement of the epidural
venous plexus exacerbated by increased
vena cava compression from higher intraabdominal pressure.8,16-18 Magnetic
resonance imaging studies have shown
that obese women have decreased cerebrospinal fluid volume but have not
shown a clear relationship between
epidural space fat distribution and
370.e4
SMFM Papers
BMI.19,20 The idea that maternal obesity
distorts the epidural space is supported
by 2 studies by Hodgkinson and Hussain6,7 that show that increasing BMI
and weight increase the cephalad spread
of epidural anesthesia, however Milligan
et al21 found no relationship between
obesity and cephalad spread. Obese
women have been found to require lower
epidural bupivacaine doses to achieve
similar quality of analgesia to normalweight women; supporting the idea that
decreased epidural space volumes and
increased epidural space pressures in
obese women lead to higher concentration and greater cephalad spread of a
given anesthetic dose.8 We propose that
our finding of more frequent hypotension among morbidly obese women can
be explained by similar mechanisms of
reduced volume and increased pressure
of the epidural space.
Another plausible explanation for the
increased incidence of hypotension in
morbidly obese women is inadequate
volume preloading related to greater circulating blood volumes. Morbidly obese
women have a higher circulating blood
volume and cardiac output of normalweight women.22 Volume preloading
with 500-1000 mL of intravenous solutions has been shown to decrease the incidence of maternal hypotension following regional anesthesia placement and
has become standard practice.14 In our
study, women in both groups received a
standard 500-mL crystalloid intravenous
fluid bolus immediately before epidural
dosing; this may have been inadequate
for morbidly obese women with twice
the circulating blood volumes compared
to normal-weight women. It is likely that
morbidly obese women require greater
volumes of intravenous fluid to achieve
adequate volume preloading prior to regional anesthesia placement.
The findings of our study suggest that
standard obstetric anesthesia practices
with established safety profiles in normal-weight women could be inappropriate for morbidly obese women. Simple alterations to anesthesia protocols,
including decreased anesthetic bolus
doses and increased volume preloading,
may achieve adequate pain control in
morbidly obese women while decreasing
370.e5
www.AJOG.org
TABLE 4
Variable
Coefficient
Adjusted OR
95% CI
BMI, kg/m
0.006
1.06
1.021.10
..............................................................................................................................................................................................................................................
2
Diastolic hypotension
BMI, kg/m
0.002
1.04
1.011.06
Volume anesthetic
0.048
1.33
1.001.77
BMI, kg/m
0.007
1.04
1.011.07
Systolic hypotension
0.003
4.21
1.6310.85
Diastolic hypotension
0.002
2.80
1.465.34
.........................................................................................................................................................................
..............................................................................................................................................................................................................................................
2
New-onset late or
prolonged decelerations
.........................................................................................................................................................................
.........................................................................................................................................................................
..............................................................................................................................................................................................................................................
Controlled for chronic hypertension, preeclampsia spectrum disorders, and epidural anesthetic volume.
BMI, body mass index; CI, confidence interval; OR, odds ratio.
Vricella. Morbid obesity and epidural anesthetic complication for labor. Am J Obstet Gynecol 2011.
the risk of maternal hypotension and resultant FHR abnormalities. In the morbidly obese obstetric population already
known to be at increased risk for emergent cesarean delivery during which they
are at greater risk for general anesthesia,
failed intubation, and death, epiduralrelated hypotension has potentially severe consequences.23,24
This study is limited by its retrospective nature. It is plausible that the actual
volume of intravenous fluid preload administered could have differed from
what was recorded. Variations in technique for measuring blood pressure have
been shown to falsely elevate readings.
However, techniques in epidural dosing
and vital sign measurement after epidural are standardized, providing an intervention and measures that are objective
and reproducible. The strengths of this
study include the adequate sample size to
measure the primary outcome and the
effective matching maintaining similarity among groups.
We failed to demonstrate significant
differences in need for intravenous pressor support. However, the power to detect the demonstrated 30% increase in
these outcomes was just 17% based on
our sample size. Similarly, although
morbidly obese women had more frequent emergent deliveries (operative
vaginal and cesarean delivery), the study
was not powered to detect a relationship
between incidence of epidural-related
maternal hypotension and emergent delivery. A larger study focusing on the
incidence of profound maternal hypo-
SMFM Papers
www.AJOG.org
4. Tabash K, Rudelstorfer R, Nuwayhid B, et al.
Circulatory responses to hypovolemia in the
pregnant and nonpregnant sheep after pharmacologic sympathectomy. Am J Obstet Gynecol 1986;154:411-9.
5. Ralston DH, Shnider SM. The fetal and neonatal effects of regional anesthesia in obstetrics.
Anesthesiology 1978;48:34-64.
6. Hodgkinson R, Hussain FJ. Obesity and the
cephalad spread of analgesia following epidural
administration of bupivacaine for cesarean section. Anesth Analg 1980;59:89-92.
7. Hodgkinson R, Hussain FJ. Obesity, gravity,
and spread of epidural anesthesia. Anesth
Analg 1981;60:421-4.
8. Panni MK, Columb MO. Obese parturients
have lower epidural local anesthetic requirements for analgesia in labor. Br J Anaesth
2006;96:106-10.
9. Dahlgren G, Irestedt L. The definition of hypotension affects its incidence. Acta Anaesthesiol Scand 2010;54:907-8.
10. Klhr S, Roth R, Hofmann T, et al. Definitions of hypotension after spinal anesthesia for
cesarean section: literature search and application to parturients. Acta Anaesthesiol Scand
2010;54:909-21.
11. Macones GA, Hankins GDV, Spong CY, et
al. The 2008 National Institute of Child Health
370.e6